Key Takeaways
- Neonatal abstinence syndrome (NAS) is a withdrawal syndrome in newborns exposed to opioids prenatally
- NAS is treatable; with proper care, infants recover fully without permanent harm
- Medication-assisted treatment during pregnancy prevents NAS and supports maternal recovery
- Compassionate perinatal care integrates maternal addiction treatment with newborn care
- Early bonding and family-centered NICU care improve outcomes for mothers and babies
What Is Neonatal Abstinence Syndrome?
Neonatal abstinence syndrome (NAS) is a withdrawal syndrome that occurs when a newborn is exposed to opioids (prescription painkillers, heroin, or maintenance medications like methadone or buprenorphine) during pregnancy. When a pregnant person uses opioids, the drug crosses the placental barrier and reaches the fetus. The fetus becomes physically dependent—meaning the baby's developing brain and body adapt to the presence of the drug, expecting it to be there. At birth, the source of opioids is suddenly cut off. The newborn then experiences withdrawal—a constellation of symptoms that reflects the baby's nervous system struggling without the drug it had adapted to.
NAS is a medical condition, not a punishment or reflection of maternal failure. A baby experiencing NAS is not suffering from addiction (babies cannot be addicted in the psychological sense). Instead, the baby is experiencing physical dependence and withdrawal—a treatable medical condition. With appropriate medical care, nearly all infants with NAS recover fully without permanent harm. The goal of NAS care is to manage withdrawal symptoms and support the baby through the transition to a drug-free state. Simultaneously, maternal treatment ensures that the mother is stable, supported, and able to care for her baby.
The severity of NAS varies depending on the specific substance, duration of maternal use, timing (prenatal vs. at birth), maternal dose, and the baby's individual physiology. Some babies develop mild NAS and recover in days with minimal intervention. Others develop more severe withdrawal requiring medication and intensive monitoring. Healthcare providers use standardized assessments to determine each baby's needs. Untreated or undertreated NAS can be serious, but appropriately treated NAS is not dangerous to the baby.
Neonatal abstinence syndrome is a treatable medical condition. Babies with NAS who receive appropriate care recover fully without permanent harm. Medication-assisted treatment during pregnancy can prevent or minimize NAS. Call (949) 280-8360 for perinatal addiction support.
How NAS Develops During Pregnancy
Understanding how NAS develops helps explain why maternal treatment is so important.
- Pregnant person uses opioids throughout pregnancy
- Opioids cross placental barrier; fetus is exposed
- Fetus's developing nervous system adapts to opioid presence
- Fetus becomes physically dependent on the drug
- At birth, maternal opioid source stops suddenly
- Newborn's nervous system lacks the drug it had adapted to
- Withdrawal symptoms emerge as baby's body adjusts
Types of Drugs That Cause NAS
Multiple opioid substances can cause NAS, each with slightly different timing and severity patterns.
- Heroin: Rapid onset NAS (6-24 hours)
- Prescription opioids (oxycodone, hydrocodone): Gradual onset (24-48 hours)
- Methadone (maintenance): Delayed onset (48-96 hours)
- Buprenorphine (maintenance): Variable onset, often milder
- Multiple drugs: NAS patterns may be complex
Signs & Symptoms of Neonatal Abstinence Syndrome
NAS symptoms reflect hyperarousal of the nervous system—a baby's brain and body are in overdrive without the depressant effect of opioids. Parents and healthcare providers should be aware that these symptoms emerge over the first 24-72 hours (depending on substance). A baby may appear normal immediately after birth, then develop symptoms as the drug clears the system. This timeline is important because it means the baby does not need NAS care immediately but should be monitored closely in the hospital for symptom development.
Early signs of NAS include: high-pitched crying, excessive sucking (but inability to coordinate feeding), tremors or shakiness, irritability, and sleep disturbance. As withdrawal progresses, symptoms may include: diarrhea, vomiting, poor weight gain, rapid breathing, fever, and seizures (rare but serious). A baby with NAS is difficult to console, feeds poorly despite apparent hunger, and shows physical signs of nervous-system dysregulation. Parents often describe the baby as "inconsolable" or "tense." Healthcare providers use standardized assessment tools (Finnegan Scoring System) to quantify symptoms and determine treatment needs.
It is critical that parents know: these symptoms are not caused by maternal failure or poor parenting; they are a medical condition caused by prenatal opioid exposure; they are temporary and treatable; and the baby is not in pain—withdrawal is uncomfortable but not painful. With appropriate care and maternal support, most babies show significant improvement within 5-14 days, though some require several weeks of treatment. The baby's prognosis does not depend on the maternal diagnosis but on the quality of medical care the baby receives.
NAS symptoms emerge during the first 24-72 hours after birth. Hospitals monitor newborns for signs including high-pitched crying, poor feeding, tremors, and irritability. Call (949) 280-8360 if you are pregnant and using opioids to prevent NAS.
Early NAS Symptoms (First 24-48 Hours)
These symptoms appear as opioids clear from the newborn's system.
- High-pitched, persistent crying
- Excessive sucking (hunger cues)
- Difficulty feeding or poor latch
- Tremors or shakiness in hands/feet
- Irritability and restlessness
- Sleep disturbance or poor sleep
- Rapid breathing
Progressive NAS Symptoms
As withdrawal progresses, additional symptoms may develop if treatment is not provided.
- Diarrhea and watery stools
- Vomiting or poor feeding leading to poor weight gain
- Fever (from hypermetabolism)
- Tight, tense muscle tone
- Continuous movement and inability to stay still
- Mottled skin appearance
- Seizures (rare but serious; requires immediate medical attention)
Medical Treatment of NAS: Medications & Monitoring
Treatment for NAS begins with careful monitoring in the hospital to assess symptom severity. Mild cases may improve with supportive care alone (skin-to-skin contact with mother, frequent feeding, gentle handling, soothing techniques, minimizing environmental stimulation). Moderate to severe cases require medication to ease withdrawal symptoms. The most common medication is morphine, which is a safe, effective opioid that relieves withdrawal symptoms and can be gradually reduced as the baby's nervous system stabilizes. Other medications used in some cases include phenobarbital (for irritability and other symptoms) or clonidine (for sympathetic nervous system hyperactivity).
The goal of medication treatment is to provide just enough medication to keep the baby comfortable while gradually reducing the dose over time. This slow tapering allows the baby's nervous system to adjust gradually rather than experiencing the shock of sudden withdrawal. The baby remains in the hospital during this taper, usually for 5-14 days, sometimes longer. Healthcare providers continue to monitor the baby's symptoms, adjust medications as needed, and support feeding and bonding. Rooming-in (mother and baby together) is encouraged to facilitate bonding and breastfeeding, both of which support the baby's recovery.
Modern NAS treatment is highly effective. Properly treated infants with NAS have excellent outcomes with no permanent neurological damage or lasting complications. The key is early recognition of symptoms, appropriate medical management, and continued support throughout treatment. Maternal involvement—being present, providing skin-to-skin contact, participating in feeding—significantly improves both the baby's outcomes and the mother's emotional wellbeing.
NAS treatment involves medications like morphine to ease withdrawal, gradual dose reduction, supportive care, and mother-baby bonding. With proper care, babies recover fully in 5-14 days typically. Rooming-in supports maternal-infant bonding.
Supportive Care for NAS
Environmental and comfort measures are the foundation of NAS treatment.
- Skin-to-skin contact with mother (reduces stress, supports bonding)
- Frequent feeding (breast or bottle) on demand
- Gentle handling and minimal environmental stimulation
- Swaddling and soothing techniques
- Temperature regulation (babies with NAS run hot)
- Careful monitoring of feeding and weight gain
- Positioning for comfort
Medication-Based Treatment
When symptoms are moderate to severe, medications ease withdrawal and support recovery.
- 1Morphine: Primary medication for NAS; started at specific dose based on symptoms
- 2Gradual tapering: Slow reduction over 5-14+ days
- 3Phenobarbital: Used in some cases for irritability
- 4Clonidine: Used in some cases for sympathetic hyperactivity
- 5Monitoring: Regular symptom assessment and medication adjustment
- 6Goal: Minimize medication while maximizing comfort
Breastfeeding with NAS: Bonding, Nutrition & Medication Safety
Breastfeeding is strongly encouraged for babies with NAS when the mother is able. Breast milk provides optimal nutrition, reduces feeding difficulties common with bottle feeding, and facilitates skin-to-skin contact that significantly improves NAS symptoms. Breastfeeding also increases maternal oxytocin (bonding hormone), supporting maternal-infant attachment at a vulnerable time. For babies undergoing NAS treatment, having the mother present for frequent feeding sessions is therapeutically powerful. The familiarity of the mother's voice, touch, and scent calm the baby's dysregulated nervous system.
For mothers on medication-assisted treatment (methadone or buprenorphine), breastfeeding is safe and recommended. These medications pass into breast milk but at such low concentrations that they are not harmful to the baby (the baby is already exposed via maternal injection). The benefits of breastfeeding and maternal-infant bonding far outweigh the minimal medication exposure through milk. Additionally, some evidence suggests that breastfeeding babies with NAS experience shorter, milder withdrawal—though this benefit may result from the bonding and comfort rather than the milk itself.
Mothers who are breastfeeding while recovering from substance-use disorders deserve strong support and non-judgment. The combination of hormonal changes, sleep deprivation, pain from delivery, and anxiety about caring for a baby with medical needs is overwhelming. Support groups specifically for nursing mothers in recovery, lactation counseling, and hands-on postpartum support are essential. Many mothers stop breastfeeding due to lack of support or shame, not due to inability. Removing these barriers allows more mothers to continue nursing and bonding with their babies.
Breastfeeding is safe for mothers on medication-assisted treatment (methadone/buprenorphine) and beneficial for NAS babies. Lactation support, peer support groups, and postpartum mental-health care enable more mothers to breastfeed successfully.
Benefits of Breastfeeding with NAS
Breastfeeding provides multiple benefits for babies with NAS and their mothers.
- Optimal nutrition supporting rapid recovery
- Frequent skin-to-skin contact calms nervous system
- Mother's presence and comfort reduce withdrawal symptoms
- Reduces feeding difficulties (coordination, sucking)
- Facilitates maternal-infant bonding
- Increases maternal oxytocin supporting bonding
- Possible shorter NAS duration (from bonding benefits)
Medication-Assisted Treatment & Safe Breastfeeding
Mothers on MAT can safely breastfeed. The medication concentration in milk is minimal and does not harm the baby.
- Methadone: Safe for breastfeeding; minimal milk concentration
- Buprenorphine: Safe for breastfeeding; minimal milk concentration
- Baby already exposed to these medications prenatally
- Benefits of bonding and breastfeeding far exceed minimal medication exposure
- Lactation support ensures successful nursing
- Pediatrician should be aware mother is on MAT
Preventing NAS: Medication-Assisted Treatment During Pregnancy
The most effective way to prevent or minimize NAS is medication-assisted treatment (MAT) during pregnancy. When a pregnant person uses heroin or non-prescribed opioids, there is high risk of NAS. However, when the person is stabilized on methadone or buprenorphine during pregnancy, NAS risk is significantly reduced or eliminated. This is because maintenance medications provide steady opioid levels that prevent the dramatic fluctuations of street-drug use, which means the fetus is in a more stable environment. At birth, the baby has adapted to a consistent medication dose that is then gradually tapered, resulting in milder withdrawal than exposure to street drugs would cause.
Medication-assisted treatment during pregnancy also supports maternal health and reduces many of the risks of untreated substance-use disorder during pregnancy. Untreated opioid addiction during pregnancy increases risks of: miscarriage, preterm birth, intrauterine growth restriction, stillbirth, and maternal complications. MAT reduces these risks dramatically. Additionally, MAT addresses the maternal substance-use disorder itself, supporting the mother's recovery and stability so she can care for her baby. A mother in recovery from addiction is in a much stronger position to navigate the challenges of having a baby with NAS.
The cultural myth that "methadone is worse than heroin" prevents some pregnant people from accepting MAT. In reality, methadone and buprenorphine are safe during pregnancy and far superior to untreated opioid addiction or non-prescribed opioid use. Comprehensive prenatal care that includes OB/GYN, addiction medicine, and pediatrics working together ensures the best outcomes for mother and baby. Pregnant people with opioid-use disorder should be encouraged (not forced or shamed) to accept MAT as a life-saving intervention for both themselves and their baby.
Medication-assisted treatment (methadone/buprenorphine) during pregnancy prevents or minimizes NAS and protects maternal health. Untreated opioid addiction in pregnancy carries serious risks. If you are pregnant and using opioids, call (949) 280-8360 immediately to discuss MAT.
How Maintenance Medications Prevent NAS
Stable maintenance medication prevents the dramatic opioid fluctuations that cause severe NAS.
- Methadone provides stable opioid levels (once daily dosing)
- Buprenorphine provides stable opioid levels (once or twice daily)
- Fetus adapted to consistent medication dose
- At birth, gradual tapering causes mild withdrawal
- NAS risk greatly reduced compared to street-drug exposure
- Maternal stability supports prenatal care and fetal health
Reducing Pregnancy Risks with MAT
MAT protects both mother and baby from serious pregnancy complications.
- 1Reduces miscarriage risk (untreated addiction increases)
- 2Reduces preterm birth and low birth weight
- 3Prevents intrauterine growth restriction
- 4Reduces stillbirth risk
- 5Supports maternal health and prenatal care compliance
- 6Enables stable, healthy pregnancy
- 7Reduces NAS severity in newborn
- 8Supports maternal recovery and parenting capacity
Family-Centered Neonatal Care: Supporting Mother & Baby During NAS Treatment
Caring for a baby with NAS is emotionally and physically demanding. Mothers often experience intense guilt ("My drug use caused this"), anxiety ("Will my baby be okay?"), grief (if custody is at risk), sleep deprivation, and the exhaustion of caring for a medically-needy newborn. Additionally, if the mother is in early recovery from addiction, she is navigating her own needs for stability, treatment participation, and emotional healing while caring for a vulnerable baby. Family-centered neonatal care recognizes and addresses the whole family system.
Effective family-centered care includes: rooming-in (mother and baby together in hospital); encouraging maternal participation in baby care; providing maternal support groups with other mothers whose babies had NAS; mental-health support for postpartum mood; peer specialists (mothers in recovery) mentoring new mothers; education about NAS to reduce shame and guilt; and clear communication with the family about the baby's prognosis (most babies recover fully). When mothers are treated with compassion and supported in bonding with their babies, they are more likely to stay in their own treatment and build strong parent-child relationships.
Some hospitals provide "therapeutic nurseries" where mothers and babies can stay together during NAS treatment, with nursing staff providing education and support rather than separation. This model dramatically improves outcomes for both mother and baby. The mother feels less ashamed and guilty; the baby has consistent maternal presence supporting recovery; and the bonding that begins during this vulnerable time carries forward into healthier parent-child relationships. This family-centered approach is more effective than traditional NICU care that separates mother from baby.
Family-centered NAS care keeps mothers and babies together, supports maternal recovery, and improves bonding. This model produces better outcomes than separation. Ask your hospital about rooming-in options. Call (949) 280-8360 for perinatal support.
Rooming-In & Maternal Presence During NAS Treatment
Mothers staying with their babies during NAS treatment significantly improves outcomes.
- Maternal presence calms baby's dysregulated nervous system
- Frequent skin-to-skin contact reduces NAS symptoms
- Mother learns to recognize and respond to baby's needs
- Bonding begins in critical early period
- Reduces maternal guilt and shame
- Increases maternal confidence in parenting
- Facilitates successful breastfeeding
Mental Health & Support Services for Mothers
Mothers experiencing NAS with their babies need integrated mental-health support.
- Screening for postpartum depression and anxiety
- Peer support groups with other mothers of NAS babies
- Individual therapy addressing guilt and trauma
- Medication management if needed (safe during breastfeeding)
- Ongoing addiction treatment participation
- Family counseling addressing relationships
- Childcare support enabling mother's own care needs
Custody, CPS Involvement & Navigating Systems During NAS
Many mothers with opioid-use disorders are terrified that having a baby with NAS will result in loss of custody or CPS involvement. While substance-use disorder and NAS are concerning, they do not automatically trigger removal. The focus of modern child-protective systems should be on supporting the mother in treatment and recovery while keeping the family together, when safe. Mothers who engage in their own addiction treatment, prenatal and postnatal care, and parenting support are often able to keep their babies.
However, the reality is that CPS involvement varies widely by jurisdiction and individual caseworker. Some jurisdictions have implemented "family first" approaches where the focus is on supporting maternal recovery rather than removal. Other jurisdictions maintain more punitive approaches. Mothers should know their rights: they have the right to consult with an attorney, the right to treatment and support services, the right to supervised visits if separation occurs, and the right to petition for reunification if safety concerns are addressed. Legal advocacy organizations in many areas provide free or low-cost legal support for mothers in these situations.
Proactive steps reduce risk of CPS involvement or custody loss: (1) Engaged prenatal care with addiction medicine providers; (2) Medication-assisted treatment during pregnancy; (3) Clean drug screens before and after delivery; (4) Demonstration of stable housing, income, and support system; (5) Completion of parenting classes and mental-health treatment; (6) Clear plan for ongoing addiction treatment and support after delivery. Mothers should connect with legal advocates early in pregnancy to understand their rights and build a supportive case.
CPS involvement with NAS is not automatic, especially if mother is engaged in treatment. Legal advocacy, treatment engagement, and comprehensive prenatal/postpartum care reduce risk. Call (949) 280-8360 for support coordinating these services.
Rights & Legal Protections During NAS & CPS Involvement
Mothers have rights even if CPS becomes involved.
- Right to legal representation (consult attorney immediately)
- Right to treatment and support services
- Right to supervised visits with baby if separation occurs
- Right to petition for reunification once safety addressed
- Right to confidential treatment records
- Right to refuse searches without warrant
- Right to fair and transparent CPS process
Protective Factors Reducing CPS Risk
Demonstrating these factors reduces likelihood of custody loss or removal.
- 1Engaged prenatal care with addiction medicine provider
- 2Medication-assisted treatment during pregnancy
- 3Clean drug screens before and after delivery
- 4Stable housing, employment, and income
- 5Strong support system (partner, family, friends)
- 6Completion of parenting classes and mental-health treatment
- 7Clear plan for ongoing treatment and support
- 8Documented engagement in treatment and recovery
Trust SoCal Editorial Team, Clinical Review Board
Editorial & Clinical Review
